US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

37.11

-0.3800-1.01%

Post-market: 37.110.00000.00%16:20 EDT

Volume:817.70K

Turnover:30.35M

Market Cap:3.50B

PE:-6.32

High:37.90

Open:37.22

Low:36.36

Close:37.49

Loading ...

Overview Company News Filings

BRIEF-Ultragenyx Q4 EPS USD -1.39 Vs. IBES Estimate USD -1.29

Ultragenyx Q4 Operating Expenses USD 287 Million

THOMSON REUTERS

Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4% PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS

Frank Sands Reduces Stake in Ultragenyx Pharmaceutical Inc.

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update

Ultragenyx Pharmaceutical Presents New Data for UX111 Gene Therapy, Expects FDA Approval Decision in H2

MT Newswires Live

Ultragenyx announces new data on UX111 AV gene therapy

Ultragenyx Pharmaceutical Inc - Pdufa Decision and Potential U.S. Launch Expected in H2 2025

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc - Mitt Group Shows +22.7 Point Treatment Effect in Bayley-Iii Cognitive Score

THOMSON REUTERS

Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustained Reductions in CSF-HS

Wedbush Trims Price Target on Ultragenyx Pharmaceutical to $47 From $48, Keeps Neutral Rating

MT Newswires Live

Ultragenyx Pharma Price Target Maintained With a $118.00/Share by Cantor Fitzgerald

Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock?

U.S. RESEARCH ROUNDUP- Apple, Murphy USA, UnitedHealth

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Why Ultragenyx Pharmaceutical (RARE) Is the Biotech Stock with the Biggest Upside Potential

Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside

Ultragenyx Pharma Price Target Maintained With a $48.00/Share by Wedbush

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RARE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RARE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","market":"US","secType":"STK","nameCN":"Ultragenyx Pharmaceutical","latestPrice":37.11,"timestamp":1750104000000,"preClose":37.49,"halted":0,"volume":817696,"hourTrading":{"tag":"盘后","latestPrice":37.11,"preClose":37.11,"latestTime":"16:20 EDT","volume":28531,"amount":1058785.41,"timestamp":1750105200567},"delay":0,"floatShares":90974915,"shares":94379691,"eps":-5.875417,"marketStatus":"Post-Mkt","change":-0.38,"latestTime":"06-16 18:42:27 EDT","open":37.22,"high":37.9,"low":36.3625,"amount":30349243.668901,"amplitude":0.041011,"askPrice":39,"askSize":100,"bidPrice":32.1,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.875417,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750118400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":37.49,"preHourTrading":{"tag":"盘前","latestPrice":37.8715,"preClose":37.49,"latestTime":"09:22 EDT","volume":1165,"amount":43233.692890000006,"timestamp":1750080126880},"postHourTrading":{"tag":"盘后","latestPrice":37.11,"preClose":37.11,"latestTime":"16:20 EDT","volume":28531,"amount":1058785.41,"timestamp":1750105200567},"volumeRatio":0.589864,"impliedVol":1.2475,"impliedVolPercentile":0.988},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","floatShares":90974915,"roa":"-24.51%","roe":"-377.06%","lyrEps":-6.286667,"volumeRatio":0.589864,"shares":94379691,"dividePrice":0,"high":37.9,"amplitude":0.041011,"preClose":37.49,"low":36.3625,"week52Low":29.59,"pbRate":"24.28","psRate":"5.93","week52High":60.37,"institutionHeld":0,"latestPrice":37.11,"eps":-5.875417,"divideRate":0,"volume":817696,"delay":0,"ttmEps":-5.875417,"open":37.22,"prevYearClose":42.07,"prevWeekClose":37.49,"prevMonthClose":34.03,"prevQuarterClose":36.21,"fiveDayClose":37.04,"twentyDayClose":35.61,"sixtyDayClose":38.89},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RARE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2511014572","title":"BRIEF-Ultragenyx Q4 EPS USD -1.39 Vs. IBES Estimate USD -1.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2511014572","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511014572?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:01","pubTimestamp":1739480506,"startTime":"0","endTime":"0","summary":"BRIEF-Ultragenyx Q4 EPS USD -1.39 Vs. IBES Estimate USD -1.29\n\n\nFeb 13 (Reuters) - Ultragenyx Q4 net income USD -133 million.\n\nQ4 operating expenses USD 287 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nPLX45DEC7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2511757788","title":"Ultragenyx Q4 Operating Expenses USD 287 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2511757788","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511757788?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:01","pubTimestamp":1739480461,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nPLX45DEC7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2511577918","title":"Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2511577918","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511577918?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:01","pubTimestamp":1739480460,"startTime":"0","endTime":"0","summary":"2024 Total Revenue of $560 million, exceeding guidanceCrysvita revenue of $410 million and Dojolvi revenue of $88 million 2025 Financial Guidance: Total Revenue between $640 million to $670 million, C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/13/3026271/20739/en/Ultragenyx-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE","BK4139","BK4126","OI"],"gpt_icon":0},{"id":"2511261545","title":"RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4% PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS","url":"https://stock-news.laohu8.com/highlight/detail?id=2511261545","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511261545?lang=en_us&edition=fundamental","pubTime":"2025-02-13 19:40","pubTimestamp":1739446800,"startTime":"0","endTime":"0","summary":"RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA +12.5%, ADJUSTED NET INCOME +8.4%PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS. Consolidated net revenue of  2,341.6 million for FY 2024, +12.4% or +9.2% on a like-for-like basis and at constant exchange rates . EBITDA of  865.8 million, +12.5%, revenue margin of 37.0%. Free cash flow at  535.1 million, + 79.1 million vs prior year. Net debt at  2,154.3 million, just below 2.4x EBITDA pro-forma. Acquisition of the global rights to Enjaymo from Sanofi closed at the end of November 2024; integration on track. ESG efforts recognized with inclusion in FTSE4GOOD Index series and with the confirmation of an “A” rating by MSCI. FY 2025 financial targets: Net revenue  2,600 - 2,670 million; EBITDA  970 -1,000 million; Adjusted net income  640 - 670 million. Updated three-year plan and mid-term financial targets to be presented on April 29th. Specialty & Primary Care revenue totaled  1,449.2 million for ful","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/recordati-preliminary-results-full-2024-114000879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RCDTF","YEAR","RICFY","KEY","FOR","SKIS","RARE"],"gpt_icon":1},{"id":"2511326575","title":"Frank Sands Reduces Stake in Ultragenyx Pharmaceutical Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2511326575","media":"GuruFocus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511326575?lang=en_us&edition=fundamental","pubTime":"2025-02-13 03:44","pubTimestamp":1739389491,"startTime":"0","endTime":"0","summary":"On December 31, 2024, Frank Sands (Trades, Portfolio), CEO and CIO of Sands Capital Management, executed a significant reduction in holdings of Ultragenyx Pharmaceutical Inc. The transaction involved ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2694179/frank-sands-reduces-stake-in-ultragenyx-pharmaceutical-inc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2509784065","title":"Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2509784065","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509784065?lang=en_us&edition=fundamental","pubTime":"2025-02-07 05:30","pubTimestamp":1738877400,"startTime":"0","endTime":"0","summary":"NOVATO, Calif., Feb.  06, 2025  (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for se","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/06/3022471/20739/en/Ultragenyx-to-Host-Conference-Call-for-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HST","BK4139","BK4218","BK4585","RARE","BK4181","BK4588"],"gpt_icon":0},{"id":"2509238593","title":"Ultragenyx Pharmaceutical Presents New Data for UX111 Gene Therapy, Expects FDA Approval Decision in H2","url":"https://stock-news.laohu8.com/highlight/detail?id=2509238593","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509238593?lang=en_us&edition=fundamental","pubTime":"2025-02-05 23:27","pubTimestamp":1738769258,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical  said Wednesday its UX111 gene therapy led to a statistically significant improvement in cognition, receptive communication and expressive communication among patients with Sanfilippo syndrome type A compared with natural history data in untreated patients with the rare genetic disorder that affects the brain and spinal cord.According to new data presented at a conference in San Diego, the company saw reduced levels of heparan sulfate in the cerebrospinal fluid of all patients within the first month following treatment through the August 2024 cutoff date, reporting a median drop of 65% in heparan sulfate levels and a mean duration of 34 months.Ultragenyx filed a biologics license application with US regulators seeking accelerated approval for UX111 in December, with the US Food and Drug Administration decision and a potential US launch expected during H2, it said.RARE shares were over 2% higher in recent trading.Price: 44.97, Change: +0.79, Percent Change: +1.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2509286845","title":"Ultragenyx announces new data on UX111 AV gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2509286845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509286845?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:21","pubTimestamp":1738761669,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) Pharmaceutical announced new data demonstrating treatment with UX111 AAV gene therapy led to a statistically significant improvem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-announces-new-data-on-ux111-av-gene-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-announces-new-data-on-ux111-av-gene-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2509728357","title":"Ultragenyx Pharmaceutical Inc - Pdufa Decision and Potential U.S. Launch Expected in H2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2509728357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509728357?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:03","pubTimestamp":1738760618,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW20H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2509283501","title":"Ultragenyx Pharmaceutical Inc - Mitt Group Shows +22.7 Point Treatment Effect in Bayley-Iii Cognitive Score","url":"https://stock-news.laohu8.com/highlight/detail?id=2509283501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509283501?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:03","pubTimestamp":1738760618,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW20H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2509283185","title":"Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustained Reductions in CSF-HS","url":"https://stock-news.laohu8.com/highlight/detail?id=2509283185","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509283185?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:00","pubTimestamp":1738760400,"startTime":"0","endTime":"0","summary":"Modified intent-to-treat group demonstrated +22.7 point  treatment effect in the mean Bayley-III cognitive raw score compared to natural history data . Older children with more advanced disease demonstrated retention of clinically meaningful functional abilities, including communication, ambulation and self-feeding. The latest data from the pivotal Transpher A and long-term follow-up studies will be presented at WORLDSymposium 2025. Cognitive function, expressive and receptive communication and fine and gross motor skills were measured using Bayley-III and compared to natural history data from untreated patients with reported rapid progressor phenotypes.iiMean observed raw scores on the Bayley-III domains improved compared to natural history. The model-based mean Bayley-III cognitive raw score from ages 24 to 60 months in the mITT group improved by +16 points compared to natural history patients who declined by -6.8 points, demonstrating a +22.7 point  treatment effect.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ultragenyx-announces-data-demonstrating-treatment-130000623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CSF","RARE"],"gpt_icon":0},{"id":"2505097922","title":"Wedbush Trims Price Target on Ultragenyx Pharmaceutical to $47 From $48, Keeps Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2505097922","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505097922?lang=en_us&edition=fundamental","pubTime":"2025-01-23 20:46","pubTimestamp":1737636373,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical (RARE) has an average rating of buy and mean price target of $91.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RARE"],"gpt_icon":0},{"id":"2505773352","title":"Ultragenyx Pharma Price Target Maintained With a $118.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2505773352","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505773352?lang=en_us&edition=fundamental","pubTime":"2025-01-23 00:22","pubTimestamp":1737562920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2025 11:22 ET (16:22 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0},{"id":"2505731727","title":"Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2505731727","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505731727?lang=en_us&edition=fundamental","pubTime":"2025-01-22 21:50","pubTimestamp":1737553800,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals, Inc.  shares soared 5.5% in the last trading session to close at $57.52. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.7% loss over the past four weeks.Earlier this month, the company announced robust preliminary results for the fourth quarter and full-year 2024. Preliminary net revenues from worldwide sales of Imcivree  were around $42 million for the fourth quarter of 2024 and approximately $130 million for the full year of 2024. Rhythm Pharmaceuticals also outlined key pipeline goals for 2025. This might have driven the recent share price rally.For Rhythm Pharmaceuticals, the consensus EPS estimate for the quarter has been revised 1% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on RYTM going forward to see if this recent jump can turn into more stren","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rhythm-pharmaceuticals-rytm-soars-5-135000370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","RYTM","BK4139","RARE","BK4585"],"gpt_icon":0},{"id":"2505213616","title":"U.S. RESEARCH ROUNDUP- Apple, Murphy USA, UnitedHealth","url":"https://stock-news.laohu8.com/highlight/detail?id=2505213616","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505213616?lang=en_us&edition=fundamental","pubTime":"2025-01-21 14:49","pubTimestamp":1737442196,"startTime":"0","endTime":"0","summary":"Jan 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, Murphy USA and UnitedHealth on Tuesday.  HIGHLIGHTS       ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HBAN","LU2023250843.SGD","PRAX","CIVI","LU2347655156.SGD","LU2237443978.SGD","MACW.SI","AA","CHRD","SG9999001176.SGD","XIFR","APA","BK4553","LU0882574139.USD","MUSA","JAMF","LU2125154935.USD","PTCT","TFC","AAPL","SWI","RNA","NABL","HES","TX","LU0234570918.USD","LU0080751232.USD","LU2403377893.USD","LU0011850046.USD","CASY","BK4023","COP","IE000W1ABFV2.USD","SRPT","UNH","RARE","LU0056508442.USD","SG9999015978.USD","MDLZ","BRY","HSBC","CFG","LU0345769128.USD","NEP","INDB","BK4504","LU0289739699.SGD","HSY","SG9999001424.SGD","DVN"],"gpt_icon":1},{"id":"2504114205","title":"Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2504114205","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504114205?lang=en_us&edition=fundamental","pubTime":"2025-01-18 05:30","pubTimestamp":1737149400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250117:nTUA2HTJHQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2504140031","title":"Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2504140031","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504140031?lang=en_us&edition=fundamental","pubTime":"2025-01-18 05:30","pubTimestamp":1737149400,"startTime":"0","endTime":"0","summary":"NOVATO, Calif., Jan.  17, 2025  (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/17/3011712/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","RARE","IE00B3QW5Z07.USD","BK4139","LU2210149790.SGD","IE00B64PRP62.GBP","LU2095319765.USD","IE00BGHQF748.EUR","LU2210150020.SGD","NDAQ","BK4112","IE00BKPKM429.USD","BK4585",".IXIC"],"gpt_icon":0},{"id":"2504191669","title":"Why Ultragenyx Pharmaceutical (RARE) Is the Biotech Stock with the Biggest Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2504191669","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504191669?lang=en_us&edition=fundamental","pubTime":"2025-01-18 00:14","pubTimestamp":1737130478,"startTime":"0","endTime":"0","summary":"We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc.  stands against other biotech stocks with the biggest upside potential.While 2024 was a “challenging” year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months. On November 28, Johan Hueffer, senior partner and principal of investments at Novo Holdings, appeared on CNBC to discuss his macro perspective on investments in life sciences. He said that biotechs faced difficulty raising capital in the last couple of years. However, that trend has started to improve in the last quarter or two.Flood’s note also highlighted that the biotech industry has recently shown improved fundamentals, attributed to a more favorable regulatory environment and positive clinical outcomes. Despite these tailwinds, Goldman’s data reflects that biotechnology ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-ultragenyx-pharmaceutical-rare-biotech-161438189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["US5Y.BOND","SQQQ","US6M.BOND","NQmain","BK4139","NVIW.SI","LU1668664300.SGD","IE0034235188.USD","LU2237443895.HKD","BK4552","US2Y.BOND","LU1791807156.HKD","BK4533","LU2237443549.SGD","IE0002270589.USD","LU0106831901.USD","IE0004086264.USD","LU2237443622.USD","IE00BSNM7G36.USD","BK4127","QLD","IE0004091025.USD","IE00B19Z3B42.SGD","US30Y.BOND","BK4516","IE00BFXG1179.USD","BK4077","TSYW.SI","BK4588","US12M.BOND","BK4585","LU2237443382.USD","QID","USAW.SI","TQQQ","BK4550","US3Y.BOND","IE00B19Z3581.USD",".IXIC","PSQ","USJW.SI","FOMC","BK4504","US7Y.BOND","LU2237438978.USD","MNQmain","LU2237443978.SGD","US10Y.BOND","RARE"],"gpt_icon":1},{"id":"2503678676","title":"Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2503678676","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503678676?lang=en_us&edition=fundamental","pubTime":"2025-01-16 03:05","pubTimestamp":1736967935,"startTime":"0","endTime":"0","summary":"In conjunction with the 2025 J.P. Morgan Healthcare Conference, the analyst hosted an investor lunch with Ultragenyx Pharmaceutical Inc .The analyst keeps an Overweight rating on Ultragenyx with a price target of $102 and says the company is uniquely positioned in the long term with an expansive and diverse pipeline of orphan disease assets and highly regarded management. JP Morgan sees multiple value-creating catalysts over the next six to 18 months.Ultragenyx’s recent meeting focused on setrusumab and the ongoing Phase 3 ORBIT trial. The analyst noted that the company remains confident in the trial’s success, with a second interim analysis expected by mid-2025 and final results by the end of 2025.At current share levels, the analyst noted the market is not fully valuing the setrusumab program and anticipates positive trial data could push Ultragenyx stock price to a ~$7-handle.Ultragenyx emphasized that moving forward to the second interim analysis does not change the study’s likelih","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ultragenyxs-multiple-commercial-assets-candidates-190535917.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0225283273.USD","LU2089284900.SGD","LU2089283258.USD","RARE","BK4504","LU0267386448.USD","LU2023251221.USD","LU1989772840.SGD","LU1548497426.USD","LU0158827948.USD","LU1074936037.SGD","BK4139","LU0098860793.USD","LU2111349929.HKD","LU2357305700.SGD","LU2028103732.USD","LU1732800096.USD","LU1363072403.SGD","BK4516","LU0106261372.USD","LU0320765646.SGD","BK4127","IE00BKVL7J92.USD","LU0006306889.USD","LU1989772923.USD","LU0795875086.SGD","BK4585","IE00BZ1G4Q59.USD","LU1162221912.USD","LU1720051017.SGD","BK4534","LU0106831901.USD","LU1720051108.HKD","LU0912757837.SGD","LU0314104364.USD","BK4581","LU2271345857.HKD","LU1732799900.SGD","BK4588","LU1668664300.SGD","LU0795875169.SGD","LU2347655156.SGD","LU0158827781.USD","LU0971096721.USD"],"gpt_icon":0},{"id":"2503819585","title":"Ultragenyx Pharma Price Target Maintained With a $48.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2503819585","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503819585?lang=en_us&edition=fundamental","pubTime":"2025-01-13 22:49","pubTimestamp":1736779740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RARE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2025 09:49 ET (14:49 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RARE"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":135,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RARE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"RARE","fiscalQuarterEnding":"2025/03","expectedEps":-1.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-1.57},{"market":"US","date":"2025-02-13","symbol":"RARE","fiscalQuarterEnding":"2024/12","expectedEps":-1.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2025-01-12","symbol":"RARE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736658000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-05","symbol":"RARE","fiscalQuarterEnding":"2024/09","expectedEps":-1.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"post","actualEps":-1.4},{"market":"US","date":"2024-08-01","symbol":"RARE","fiscalQuarterEnding":"2024/06","expectedEps":-1.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722484800000,"reportTimeType":"post","actualEps":-1.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RARE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RARE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.619,"hold":0.0476,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.619,"analysts":21,"updateTime":1748664000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RARE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RARE","date":"2025-06-13","current":-6.747307,"percent":0.581833,"low":-57.721347,"twenty":-17.184926,"median":-7.489485,"eighty":-5.047026,"high":-3.237111,"avg":-12.758953,"sd":11.266026,"marketCap":3708178059},"quantilePoints":[{"date":"2020-06-19","current":-10.996766,"twenty":-35.515997,"median":-16.449585,"eighty":-8.83563,"marketCap":4673581563},{"date":"2020-06-26","current":-10.766202,"twenty":-34.880062,"median":-16.047057,"eighty":-8.83563,"marketCap":4575592893},{"date":"2020-07-02","current":-12.096161,"twenty":-34.533174,"median":-15.914316,"eighty":-8.83563,"marketCap":5140820221},{"date":"2020-07-10","current":-12.127091,"twenty":-34.319178,"median":-15.750943,"eighty":-8.83563,"marketCap":5153965043},{"date":"2020-07-17","current":-12.073667,"twenty":-34.165471,"median":-15.682493,"eighty":-8.83563,"marketCap":5131260351},{"date":"2020-07-24","current":-10.933502,"twenty":-33.630411,"median":-15.442169,"eighty":-8.83563,"marketCap":4646694428},{"date":"2020-07-31","current":-15.713137,"twenty":-33.403837,"median":-15.274826,"eighty":-8.83563,"marketCap":4721939168},{"date":"2020-08-07","current":-17.056072,"twenty":-33.191014,"median":-15.274826,"eighty":-8.83563,"marketCap":5125503059},{"date":"2020-08-14","current":-17.110352,"twenty":-33.044701,"median":-15.274826,"eighty":-8.83563,"marketCap":5141814773},{"date":"2020-08-21","current":-17.602895,"twenty":-32.874882,"median":-15.274826,"eighty":-8.83563,"marketCap":5289828475},{"date":"2020-08-28","current":-17.226954,"twenty":-32.672148,"median":-15.274826,"eighty":-8.83563,"marketCap":5176854751},{"date":"2020-09-04","current":-15.240698,"twenty":-32.073958,"median":-15.261678,"eighty":-8.83563,"marketCap":4579966842},{"date":"2020-09-11","current":-14.842642,"twenty":-31.733969,"median":-15.200985,"eighty":-8.83563,"marketCap":4460347605},{"date":"2020-09-18","current":-16.660027,"twenty":-31.375759,"median":-15.200985,"eighty":-8.83563,"marketCap":5006487959},{"date":"2020-09-25","current":-16.499196,"twenty":-31.265773,"median":-15.200985,"eighty":-8.83563,"marketCap":4958156954},{"date":"2020-10-02","current":-16.967615,"twenty":-31.090702,"median":-15.200985,"eighty":-8.83563,"marketCap":5098921006},{"date":"2020-10-09","current":-18.988048,"twenty":-31.037306,"median":-15.200985,"eighty":-8.83563,"marketCap":5706079254},{"date":"2020-10-16","current":-18.489473,"twenty":-30.842003,"median":-15.200985,"eighty":-8.83563,"marketCap":5556253139},{"date":"2020-10-23","current":-18.708605,"twenty":-30.644242,"median":-15.200985,"eighty":-8.83563,"marketCap":5622104133},{"date":"2020-10-30","current":-25.673497,"twenty":-30.489754,"median":-15.200985,"eighty":-8.83563,"marketCap":6581657766},{"date":"2020-11-06","current":-28.752844,"twenty":-30.231689,"median":-15.200985,"eighty":-8.83563,"marketCap":7371079013},{"date":"2020-11-13","current":-30.249581,"twenty":-30.174442,"median":-15.200985,"eighty":-8.83563,"marketCap":7754782641},{"date":"2020-11-20","current":-29.514115,"twenty":-30.01147,"median":-15.200985,"eighty":-8.83563,"marketCap":7566238617},{"date":"2020-11-27","current":-31.591484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":8098792791},{"date":"2020-12-04","current":-33.168219,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":8503004716},{"date":"2020-12-11","current":-37.402954,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9588621362},{"date":"2020-12-18","current":-43.364099,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":11116820295},{"date":"2020-12-24","current":-44.61052,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":11436352800},{"date":"2020-12-31","current":-35.722995,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9157947117},{"date":"2021-01-08","current":-38.860983,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9962401620},{"date":"2021-01-15","current":-35.604289,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9127515450},{"date":"2021-01-22","current":-36.249434,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9292904945},{"date":"2021-01-29","current":-35.764285,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9168532044},{"date":"2021-02-05","current":-41.8622,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10731793551},{"date":"2021-02-12","current":-53.920829,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10059793403},{"date":"2021-02-19","current":-53.160067,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9917861006},{"date":"2021-02-26","current":-50.791655,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9475995995},{"date":"2021-03-05","current":-42.523747,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7933485414},{"date":"2021-03-12","current":-45.556031,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8499206525},{"date":"2021-03-19","current":-44.759384,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8350579204},{"date":"2021-03-26","current":-38.985484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7273365868},{"date":"2021-04-01","current":-40.621841,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7578654420},{"date":"2021-04-09","current":-37.133817,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6927907769},{"date":"2021-04-16","current":-39.014192,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7278721807},{"date":"2021-04-23","current":-39.42687,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7355713438},{"date":"2021-04-30","current":-40.376431,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7532869144},{"date":"2021-05-07","current":-37.945412,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7728797410},{"date":"2021-05-14","current":-36.736115,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7482485435},{"date":"2021-05-21","current":-35.563263,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7243596560},{"date":"2021-05-28","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-04","current":-30.543853,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6221233155},{"date":"2021-06-11","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-18","current":-31.448341,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6405461016},{"date":"2021-06-25","current":-31.087209,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":6331904837},{"date":"2021-07-02","current":-31.213108,"twenty":-30.257731,"median":-15.161272,"eighty":-8.834973,"marketCap":6357548275},{"date":"2021-07-09","current":-30.262236,"twenty":-30.265324,"median":-15.161272,"eighty":-8.834973,"marketCap":6163872832},{"date":"2021-07-16","current":-28.271038,"twenty":-30.233301,"median":-15.161272,"eighty":-8.834973,"marketCap":5758301606},{"date":"2021-07-23","current":-27.406308,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":5582171673},{"date":"2021-07-30","current":-26.44881,"twenty":-29.79768,"median":-15.161272,"eighty":-8.834973,"marketCap":5387146575},{"date":"2021-08-06","current":-17.083279,"twenty":-29.687102,"median":-15.161272,"eighty":-8.834973,"marketCap":6003491310},{"date":"2021-08-13","current":-17.901732,"twenty":-29.496644,"median":-15.161272,"eighty":-8.834973,"marketCap":6291116204},{"date":"2021-08-20","current":-15.473397,"twenty":-29.315394,"median":-15.15171,"eighty":-8.834973,"marketCap":5437738569},{"date":"2021-08-27","current":-18.1353,"twenty":-29.179331,"median":-15.15171,"eighty":-8.834973,"marketCap":6373197837},{"date":"2021-09-03","current":-19.766415,"twenty":-28.984947,"median":-15.15171,"eighty":-8.834973,"marketCap":6946412544},{"date":"2021-09-10","current":-19.629363,"twenty":-28.634625,"median":-15.15171,"eighty":-8.834973,"marketCap":6898248941},{"date":"2021-09-17","current":-18.969196,"twenty":-28.497709,"median":-15.15171,"eighty":-8.834973,"marketCap":6666249616},{"date":"2021-09-24","current":-18.359217,"twenty":-28.236842,"median":-15.15171,"eighty":-8.834973,"marketCap":6451887666},{"date":"2021-10-01","current":-16.948157,"twenty":-28.151413,"median":-15.15171,"eighty":-8.834973,"marketCap":5956006068},{"date":"2021-10-08","current":-15.759084,"twenty":-28.053185,"median":-15.15171,"eighty":-8.834973,"marketCap":5538135938},{"date":"2021-10-15","current":-15.442512,"twenty":-27.812745,"median":-15.15171,"eighty":-8.834973,"marketCap":5426884800},{"date":"2021-10-22","current":-15.098916,"twenty":-27.55852,"median":-15.082382,"eighty":-8.834973,"marketCap":5306136613},{"date":"2021-10-29","current":-16.199195,"twenty":-27.366816,"median":-15.082382,"eighty":-8.834973,"marketCap":5692802155},{"date":"2021-11-05","current":-15.975791,"twenty":-27.236045,"median":-15.082382,"eighty":-8.834973,"marketCap":5680639831},{"date":"2021-11-12","current":-15.43713,"twenty":-27.171258,"median":-15.082382,"eighty":-8.834973,"marketCap":5489103979},{"date":"2021-11-19","current":-15.205181,"twenty":-26.927437,"median":-15.06031,"eighty":-8.834973,"marketCap":5406627687},{"date":"2021-11-26","current":-14.662686,"twenty":-26.731524,"median":-14.936554,"eighty":-8.834973,"marketCap":5213728590},{"date":"2021-12-03","current":-14.570673,"twenty":-26.554402,"median":-14.855697,"eighty":-8.834973,"marketCap":5181010722},{"date":"2021-12-10","current":-14.932975,"twenty":-26.360162,"median":-14.855697,"eighty":-8.834973,"marketCap":5309837327},{"date":"2021-12-17","current":-16.265249,"twenty":-26.205264,"median":-14.855697,"eighty":-8.834973,"marketCap":5783564791},{"date":"2021-12-23","current":-16.244163,"twenty":-25.908959,"median":-14.855697,"eighty":-8.834973,"marketCap":5776066946},{"date":"2021-12-31","current":-16.119562,"twenty":-25.241061,"median":-14.855697,"eighty":-8.834973,"marketCap":5731761500},{"date":"2022-01-07","current":-14.145112,"twenty":-24.735967,"median":-14.855038,"eighty":-8.83563,"marketCap":5029690582},{"date":"2022-01-14","current":-13.811564,"twenty":-24.180303,"median":-14.806289,"eighty":-8.83563,"marketCap":4911088311},{"date":"2022-01-21","current":-12.876097,"twenty":-23.989848,"median":-14.747324,"eighty":-8.83563,"marketCap":4578456653},{"date":"2022-01-28","current":-12.651814,"twenty":-23.661155,"median":-14.661474,"eighty":-8.83563,"marketCap":4498706850},{"date":"2022-02-04","current":-13.154053,"twenty":-23.48091,"median":-14.600648,"eighty":-8.83563,"marketCap":4677291879},{"date":"2022-02-11","current":-10.94589,"twenty":-23.205637,"median":-14.505395,"eighty":-8.83563,"marketCap":4969707824},{"date":"2022-02-18","current":-10.194721,"twenty":-23.125145,"median":-14.35823,"eighty":-8.83563,"marketCap":4628658273},{"date":"2022-02-25","current":-10.307809,"twenty":-22.914219,"median":-14.283419,"eighty":-8.83563,"marketCap":4680003006},{"date":"2022-03-04","current":-9.594133,"twenty":-22.459434,"median":-14.16111,"eighty":-8.83563,"marketCap":4355976111},{"date":"2022-03-11","current":-9.996053,"twenty":-21.586553,"median":-14.118393,"eighty":-8.83563,"marketCap":4538458067},{"date":"2022-03-18","current":-10.663883,"twenty":-21.326675,"median":-14.069914,"eighty":-8.83563,"marketCap":4841669529},{"date":"2022-03-25","current":-10.524816,"twenty":-21.159681,"median":-13.968769,"eighty":-8.83563,"marketCap":4778529385},{"date":"2022-04-01","current":-11.823798,"twenty":-21.003206,"median":-13.863231,"eighty":-8.83563,"marketCap":5368299964},{"date":"2022-04-08","current":-12.514551,"twenty":-20.910296,"median":-13.803148,"eighty":-8.83563,"marketCap":5681919142},{"date":"2022-04-14","current":-13.050955,"twenty":-20.848103,"median":-13.773354,"eighty":-8.83563,"marketCap":5925459699},{"date":"2022-04-22","current":-11.470781,"twenty":-20.717776,"median":-13.670793,"eighty":-8.83563,"marketCap":5208021136},{"date":"2022-04-29","current":-10.878745,"twenty":-20.624785,"median":-13.564241,"eighty":-8.83563,"marketCap":4939222202},{"date":"2022-05-06","current":-8.557526,"twenty":-20.519008,"median":-13.487652,"eighty":-8.833003,"marketCap":4023783190},{"date":"2022-05-13","current":-7.654777,"twenty":-20.519008,"median":-13.402239,"eighty":-8.786823,"marketCap":3599306930},{"date":"2022-05-20","current":-7.220506,"twenty":-20.519008,"median":-13.35812,"eighty":-8.748709,"marketCap":3395110773},{"date":"2022-05-27","current":-7.233891,"twenty":-20.519008,"median":-13.323757,"eighty":-8.718034,"marketCap":3401404490},{"date":"2022-06-03","current":-7.645854,"twenty":-20.519008,"median":-13.277877,"eighty":-8.684283,"marketCap":3595111119},{"date":"2022-06-10","current":-7.418308,"twenty":-20.519008,"median":-13.17025,"eighty":-8.65258,"marketCap":3488117927},{"date":"2022-06-17","current":-7.925453,"twenty":-20.519008,"median":-13.057111,"eighty":-8.633594,"marketCap":3726579878},{"date":"2022-06-24","current":-9.008157,"twenty":-20.52732,"median":-13.025475,"eighty":-8.615488,"marketCap":4235671668},{"date":"2022-07-01","current":-9.317501,"twenty":-20.52732,"median":-12.971944,"eighty":-8.615488,"marketCap":4381126466},{"date":"2022-07-08","current":-9.836545,"twenty":-20.52732,"median":-12.903988,"eighty":-8.615488,"marketCap":4625182832},{"date":"2022-07-15","current":-9.62982,"twenty":-20.52732,"median":-12.867014,"eighty":-8.615488,"marketCap":4527979867},{"date":"2022-07-22","current":-7.657752,"twenty":-20.52732,"median":-12.683542,"eighty":-8.593044,"marketCap":3600705534},{"date":"2022-07-29","current":-7.375537,"twenty":-20.52732,"median":-12.576503,"eighty":-8.565198,"marketCap":3731564327},{"date":"2022-08-05","current":-7.696694,"twenty":-20.52732,"median":-12.447093,"eighty":-8.50432,"marketCap":3894049860},{"date":"2022-08-12","current":-7.138822,"twenty":-20.52732,"median":-12.354843,"eighty":-8.455092,"marketCap":3611801282},{"date":"2022-08-19","current":-6.78721,"twenty":-20.52732,"median":-12.331685,"eighty":-8.434672,"marketCap":3433907638},{"date":"2022-08-26","current":-6.852272,"twenty":-20.52732,"median":-12.331685,"eighty":-8.389678,"marketCap":3466824966},{"date":"2022-09-02","current":-6.61002,"twenty":-20.52732,"median":-12.331685,"eighty":-8.359036,"marketCap":3344260447},{"date":"2022-09-09","current":-6.816281,"twenty":-20.52732,"median":-12.331685,"eighty":-8.331801,"marketCap":3448615380},{"date":"2022-09-16","current":-6.371921,"twenty":-20.52732,"median":-12.331685,"eighty":-8.289414,"marketCap":3223797034},{"date":"2022-09-23","current":-5.744834,"twenty":-20.52732,"median":-12.331685,"eighty":-8.245615,"marketCap":2906530022},{"date":"2022-09-30","current":-5.732376,"twenty":-20.52732,"median":-12.331685,"eighty":-8.208124,"marketCap":2900226703},{"date":"2022-10-07","current":-5.25064,"twenty":-20.52732,"median":-12.331685,"eighty":-8.150659,"marketCap":2656498403},{"date":"2022-10-14","current":-5.130206,"twenty":-20.52732,"median":-12.331685,"eighty":-8.077486,"marketCap":2595566328},{"date":"2022-10-21","current":-5.328161,"twenty":-20.52732,"median":-12.331685,"eighty":-8.010065,"marketCap":2695719049},{"date":"2022-10-28","current":-5.642396,"twenty":-20.52732,"median":-12.331685,"eighty":-7.967887,"marketCap":2854702739},{"date":"2022-11-04","current":-3.646694,"twenty":-20.52732,"median":-12.331685,"eighty":-7.881082,"marketCap":2472626416},{"date":"2022-11-11","current":-3.779038,"twenty":-20.52732,"median":-12.331685,"eighty":-7.854126,"marketCap":2562361653},{"date":"2022-11-18","current":-3.721138,"twenty":-20.52732,"median":-12.331685,"eighty":-7.7969,"marketCap":2523102487},{"date":"2022-11-25","current":-3.693221,"twenty":-20.52732,"median":-12.331685,"eighty":-7.738619,"marketCap":2504173960},{"date":"2022-12-02","current":-4.153323,"twenty":-20.52732,"median":-12.331685,"eighty":-7.69117,"marketCap":2816144121},{"date":"2022-12-09","current":-4.202952,"twenty":-20.52732,"median":-12.331685,"eighty":-7.649461,"marketCap":2849794835},{"date":"2022-12-16","current":-4.717852,"twenty":-20.52732,"median":-12.331685,"eighty":-7.588745,"marketCap":3198920992},{"date":"2022-12-23","current":-4.499692,"twenty":-20.52732,"median":-12.331685,"eighty":-7.55634,"marketCap":3050998062},{"date":"2022-12-30","current":-4.790228,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3247994949},{"date":"2023-01-06","current":-4.824348,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3271129815},{"date":"2023-01-13","current":-4.502794,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3053101231},{"date":"2023-01-20","current":-4.383891,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":2972479729},{"date":"2023-01-27","current":-4.520371,"twenty":-20.52732,"median":-12.331685,"eighty":-7.419224,"marketCap":3065019192},{"date":"2023-02-03","current":-4.728192,"twenty":-20.52732,"median":-12.331685,"eighty":-7.265696,"marketCap":3205931557},{"date":"2023-02-10","current":-4.549321,"twenty":-20.52732,"median":-12.331685,"eighty":-7.228067,"marketCap":3084648776},{"date":"2023-02-17","current":-4.834822,"twenty":-20.52732,"median":-12.331685,"eighty":-7.193971,"marketCap":3420254921},{"date":"2023-02-24","current":-4.342506,"twenty":-20.52732,"median":-12.331685,"eighty":-7.118611,"marketCap":3071980143},{"date":"2023-03-03","current":-4.536058,"twenty":-20.52732,"median":-12.331685,"eighty":-7.091607,"marketCap":3208902687},{"date":"2023-03-10","current":-3.847212,"twenty":-20.52732,"median":-12.331685,"eighty":-7.007538,"marketCap":2721598865},{"date":"2023-03-17","current":-3.824383,"twenty":-20.52732,"median":-12.331685,"eighty":-6.964752,"marketCap":2705449027},{"date":"2023-03-24","current":-3.740015,"twenty":-20.52732,"median":-12.331685,"eighty":-6.882782,"marketCap":2645764841},{"date":"2023-03-31","current":-3.980217,"twenty":-20.519008,"median":-12.327325,"eighty":-6.84769,"marketCap":2815689228},{"date":"2023-04-06","current":-3.845227,"twenty":-20.519008,"median":-12.327325,"eighty":-6.817229,"marketCap":2720194531},{"date":"2023-04-14","current":-3.834309,"twenty":-20.52732,"median":-12.331685,"eighty":-6.790561,"marketCap":2712470696},{"date":"2023-04-21","current":-4.095356,"twenty":-20.52732,"median":-12.331685,"eighty":-6.741883,"marketCap":2897140588},{"date":"2023-04-28","current":-4.242476,"twenty":-20.52732,"median":-12.331685,"eighty":-6.708105,"marketCap":3001216442},{"date":"2023-05-05","current":-4.503028,"twenty":-20.52732,"median":-12.331685,"eighty":-6.653176,"marketCap":3238005775},{"date":"2023-05-12","current":-4.638891,"twenty":-20.543943,"median":-12.127091,"eighty":-6.641982,"marketCap":3335701281},{"date":"2023-05-19","current":-5.014059,"twenty":-20.543943,"median":-12.030107,"eighty":-6.608226,"marketCap":3605474618},{"date":"2023-05-26","current":-4.91559,"twenty":-20.543943,"median":-11.942999,"eighty":-6.574925,"marketCap":3534667968},{"date":"2023-06-02","current":-4.885064,"twenty":-20.543943,"median":-11.851539,"eighty":-6.547631,"marketCap":3512717906},{"date":"2023-06-09","current":-5.079049,"twenty":-20.543943,"median":-11.661746,"eighty":-6.51973,"marketCap":3652207007},{"date":"2023-06-16","current":-4.811212,"twenty":-20.543943,"median":-11.483123,"eighty":-6.479975,"marketCap":3459612919},{"date":"2023-06-21","current":-4.936268,"twenty":-20.510696,"median":-11.421308,"eighty":-6.417082,"marketCap":3549537364},{"date":"2023-06-30","current":-4.593595,"twenty":-20.487227,"median":-11.238841,"eighty":-6.371161,"marketCap":3303130222},{"date":"2023-07-07","current":-4.482325,"twenty":-20.498962,"median":-11.187498,"eighty":-6.365701,"marketCap":3223118708},{"date":"2023-07-21","current":-4.237136,"twenty":-19.951513,"median":-11.097535,"eighty":-6.330057,"marketCap":3046810149},{"date":"2023-07-28","current":-4.134728,"twenty":-19.945557,"median":-11.07773,"eighty":-6.267685,"marketCap":2973171233},{"date":"2023-08-04","current":-4.057384,"twenty":-19.897508,"median":-11.023587,"eighty":-6.244893,"marketCap":2924314645},{"date":"2023-08-11","current":-3.621915,"twenty":-19.755822,"median":-10.996766,"eighty":-6.219342,"marketCap":2610455224},{"date":"2023-08-18","current":-3.463233,"twenty":-19.719512,"median":-10.937719,"eighty":-6.110593,"marketCap":2496086977},{"date":"2023-08-25","current":-3.666544,"twenty":-19.634346,"median":-10.899761,"eighty":-5.986933,"marketCap":2642621293},{"date":"2023-09-01","current":-3.648692,"twenty":-19.538575,"median":-10.863505,"eighty":-5.82457,"marketCap":2629754865},{"date":"2023-09-08","current":-4.080109,"twenty":-19.362208,"median":-10.802755,"eighty":-5.750563,"marketCap":2940693535},{"date":"2023-09-15","current":-3.893658,"twenty":-19.077218,"median":-10.732491,"eighty":-5.672427,"marketCap":2806310846},{"date":"2023-09-22","current":-3.630841,"twenty":-18.981061,"median":-10.679378,"eighty":-5.619716,"marketCap":2616888437},{"date":"2023-09-29","current":-3.488027,"twenty":-18.845186,"median":-10.612101,"eighty":-5.581034,"marketCap":2513957016},{"date":"2023-10-06","current":-3.468192,"twenty":-18.69861,"median":-10.535971,"eighty":-5.490331,"marketCap":2499660985},{"date":"2023-10-13","current":-3.237111,"twenty":-18.632497,"median":-10.521807,"eighty":-5.460417,"marketCap":2333112226},{"date":"2023-10-20","current":-3.7042,"twenty":-18.632497,"median":-10.443907,"eighty":-5.405085,"marketCap":2669761173},{"date":"2023-10-27","current":-3.893405,"twenty":-18.654427,"median":-10.382839,"eighty":-5.365218,"marketCap":2806128470},{"date":"2023-11-03","current":-4.68465,"twenty":-18.654427,"median":-10.364295,"eighty":-5.28414,"marketCap":2976073660},{"date":"2023-11-10","current":-4.517051,"twenty":-18.654427,"median":-10.342873,"eighty":-5.170628,"marketCap":2869601414},{"date":"2023-11-17","current":-5.034024,"twenty":-18.654427,"median":-10.305516,"eighty":-5.093229,"marketCap":3198025038},{"date":"2023-11-24","current":-5.058581,"twenty":-18.654427,"median":-10.281065,"eighty":-5.066839,"marketCap":3213625160},{"date":"2023-12-01","current":-5.0211,"twenty":-18.654427,"median":-10.19999,"eighty":-5.05703,"marketCap":3189814448},{"date":"2023-12-08","current":-5.353255,"twenty":-18.644324,"median":-10.171258,"eighty":-5.057805,"marketCap":3400826626},{"date":"2023-12-15","current":-5.933557,"twenty":-18.644324,"median":-10.119914,"eighty":-5.057805,"marketCap":3769482144},{"date":"2023-12-22","current":-5.885737,"twenty":-18.644324,"median":-10.02608,"eighty":-5.057805,"marketCap":3739102959},{"date":"2023-12-29","current":-6.238571,"twenty":-18.654427,"median":-9.99662,"eighty":-5.05703,"marketCap":3963252082},{"date":"2024-01-05","current":-6.086064,"twenty":-18.664531,"median":-9.939328,"eighty":-5.056254,"marketCap":3866367113},{"date":"2024-01-12","current":-5.964576,"twenty":-18.664531,"median":-9.900378,"eighty":-5.056254,"marketCap":3789187561},{"date":"2024-01-19","current":-5.578138,"twenty":-18.674634,"median":-9.811733,"eighty":-5.055479,"marketCap":3543690902},{"date":"2024-01-26","current":-5.848257,"twenty":-18.664531,"median":-9.7849,"eighty":-5.056254,"marketCap":3715292246},{"date":"2024-02-02","current":-5.699627,"twenty":-18.664531,"median":-9.642907,"eighty":-5.056254,"marketCap":3620870454},{"date":"2024-02-09","current":-5.874105,"twenty":-18.664531,"median":-9.594133,"eighty":-5.056254,"marketCap":3731713427},{"date":"2024-02-16","current":-6.261086,"twenty":-18.664531,"median":-9.561842,"eighty":-5.056254,"marketCap":3798219211},{"date":"2024-02-23","current":-6.634206,"twenty":-18.664531,"median":-9.488533,"eighty":-5.056254,"marketCap":4024568380},{"date":"2024-03-01","current":-7.019664,"twenty":-18.654427,"median":-9.448218,"eighty":-5.05703,"marketCap":4258401731},{"date":"2024-03-08","current":-6.901583,"twenty":-18.618504,"median":-9.331505,"eighty":-5.05703,"marketCap":4186769683},{"date":"2024-03-15","current":-6.331541,"twenty":-18.555722,"median":-9.248631,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-22","current":-6.331541,"twenty":-18.362305,"median":-9.119934,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-28","current":-6.354614,"twenty":-18.110177,"median":-9.054151,"eighty":-5.05703,"marketCap":3854956865},{"date":"2024-04-05","current":-6.389903,"twenty":-17.885675,"median":-8.975116,"eighty":-5.056254,"marketCap":3876364143},{"date":"2024-04-12","current":-6.881225,"twenty":-17.643907,"median":-8.928874,"eighty":-5.056254,"marketCap":4174419330},{"date":"2024-04-19","current":-5.887723,"twenty":-17.405641,"median":-8.865305,"eighty":-5.056254,"marketCap":3571722102},{"date":"2024-04-26","current":-5.951513,"twenty":-17.24545,"median":-8.784804,"eighty":-5.05703,"marketCap":3610419874},{"date":"2024-05-03","current":-5.85531,"twenty":-17.111877,"median":-8.730843,"eighty":-5.05703,"marketCap":3591360331},{"date":"2024-05-10","current":-5.582669,"twenty":-17.109146,"median":-8.602772,"eighty":-5.05703,"marketCap":3424135754},{"date":"2024-05-17","current":-5.770925,"twenty":-17.109146,"median":-8.502293,"eighty":-5.05703,"marketCap":3539602729},{"date":"2024-05-24","current":-5.403894,"twenty":-17.109146,"median":-8.437742,"eighty":-5.05703,"marketCap":3314483663},{"date":"2024-05-31","current":-5.234599,"twenty":-17.109146,"median":-8.326018,"eighty":-5.05703,"marketCap":3210646455},{"date":"2024-06-07","current":-5.657159,"twenty":-17.109146,"median":-8.22856,"eighty":-5.05703,"marketCap":3469824125},{"date":"2024-06-14","current":-6.362758,"twenty":-17.109548,"median":-8.139615,"eighty":-5.056254,"marketCap":3902604231},{"date":"2024-06-21","current":-5.610206,"twenty":-17.10995,"median":-8.062414,"eighty":-5.055479,"marketCap":3441025345},{"date":"2024-06-28","current":-6.111908,"twenty":-17.111877,"median":-7.980946,"eighty":-5.053152,"marketCap":3748744602},{"date":"2024-07-05","current":-5.933361,"twenty":-17.111877,"median":-7.91653,"eighty":-5.053152,"marketCap":3639232749},{"date":"2024-07-12","current":-6.476379,"twenty":-17.111877,"median":-7.842615,"eighty":-5.053152,"marketCap":3972293592},{"date":"2024-07-15","current":-6.660828,"twenty":-17.111877,"median":-7.815809,"eighty":-5.053152,"marketCap":4085425672},{"date":"2024-08-02","current":-6.829058,"twenty":-17.121885,"median":-7.700275,"eighty":-5.034024,"marketCap":3995825065},{"date":"2024-08-09","current":-7.915825,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4631715386},{"date":"2024-08-16","current":-8.142486,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4764339569},{"date":"2024-08-23","current":-8.871265,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5190763157},{"date":"2024-08-30","current":-8.965707,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5246023233},{"date":"2024-09-06","current":-8.885431,"twenty":-17.121885,"median":-7.70624,"eighty":-5.034024,"marketCap":5199052169},{"date":"2024-09-13","current":-9.102648,"twenty":-17.121885,"median":-7.774964,"eighty":-5.034024,"marketCap":5326150344},{"date":"2024-09-20","current":-9.252181,"twenty":-17.121885,"median":-7.849896,"eighty":-5.034024,"marketCap":5413645465},{"date":"2024-09-27","current":-8.691824,"twenty":-17.121885,"median":-7.916177,"eighty":-5.034024,"marketCap":5085769012},{"date":"2024-10-04","current":-8.446275,"twenty":-17.121885,"median":-7.994412,"eighty":-5.034024,"marketCap":4942092814},{"date":"2024-10-11","current":-8.47933,"twenty":-17.121885,"median":-8.063851,"eighty":-5.034024,"marketCap":4961433841},{"date":"2024-10-18","current":-8.9358,"twenty":-17.121885,"median":-8.144847,"eighty":-5.034024,"marketCap":5228524209},{"date":"2024-10-25","current":-8.628863,"twenty":-17.121885,"median":-8.21254,"eighty":-5.034024,"marketCap":5048928962},{"date":"2024-10-31","current":-8.1598,"twenty":-17.121885,"median":-8.258605,"eighty":-5.034024,"marketCap":4774470583},{"date":"2024-11-08","current":-8.324768,"twenty":-17.142899,"median":-8.319439,"eighty":-5.03169,"marketCap":4653445648},{"date":"2024-11-15","current":-7.864207,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395997435},{"date":"2024-11-22","current":-7.596785,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4246511376},{"date":"2024-11-29","current":-7.862556,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395074682},{"date":"2024-12-06","current":-7.814684,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4368314832},{"date":"2024-12-13","current":-7.7404,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4326790927},{"date":"2024-12-20","current":-7.175841,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4011209247},{"date":"2024-12-27","current":-7.233618,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4043505617},{"date":"2025-01-03","current":-6.792866,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":3797130446},{"date":"2025-01-10","current":-7.205555,"twenty":-17.163913,"median":-8.328682,"eighty":-5.029355,"marketCap":4027818809},{"date":"2025-01-17","current":-6.743343,"twenty":-17.163913,"median":-8.303187,"eighty":-5.029355,"marketCap":3769447843},{"date":"2025-01-24","current":-7.403646,"twenty":-17.163913,"median":-8.22856,"eighty":-5.029355,"marketCap":4138549223},{"date":"2025-01-31","current":-7.164286,"twenty":-17.163913,"median":-8.210902,"eighty":-5.029355,"marketCap":4004749973},{"date":"2025-02-07","current":-7.557166,"twenty":-17.163913,"median":-8.156652,"eighty":-5.029355,"marketCap":4224365294},{"date":"2025-02-14","current":-7.055416,"twenty":-17.163913,"median":-8.140574,"eighty":-5.029355,"marketCap":4015823014},{"date":"2025-02-21","current":-7.228695,"twenty":-17.163913,"median":-8.07435,"eighty":-5.029355,"marketCap":4114450084},{"date":"2025-02-28","current":-6.82078,"twenty":-17.163913,"median":-8.063851,"eighty":-5.029355,"marketCap":3882272258},{"date":"2025-03-07","current":-6.503875,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3701895062},{"date":"2025-03-14","current":-6.378738,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3630669195},{"date":"2025-03-21","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-03-28","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-04-04","current":-5.709174,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3249564556},{"date":"2025-04-11","current":-5.389018,"twenty":-17.163913,"median":-8.038932,"eighty":-5.047263,"marketCap":3067337338},{"date":"2025-04-17","current":-5.770746,"twenty":-17.163913,"median":-7.988725,"eighty":-5.047263,"marketCap":3284610351},{"date":"2025-04-25","current":-6.209573,"twenty":-17.184926,"median":-7.897222,"eighty":-5.047026,"marketCap":3534383465},{"date":"2025-05-02","current":-6.428987,"twenty":-17.184926,"median":-7.862556,"eighty":-5.047026,"marketCap":3659270022},{"date":"2025-05-09","current":-6.178877,"twenty":-17.184926,"median":-7.798177,"eighty":-5.047026,"marketCap":3395781282},{"date":"2025-05-16","current":-5.983104,"twenty":-17.184926,"median":-7.720227,"eighty":-5.047026,"marketCap":3288188434},{"date":"2025-05-23","current":-6.098164,"twenty":-17.184926,"median":-7.659513,"eighty":-5.047026,"marketCap":3351422827},{"date":"2025-05-30","current":-6.015733,"twenty":-17.184926,"median":-7.598263,"eighty":-5.047026,"marketCap":3306120575},{"date":"2025-06-06","current":-6.338587,"twenty":-17.184926,"median":-7.557166,"eighty":-5.047026,"marketCap":3483554394},{"date":"2025-06-13","current":-6.747307,"twenty":-17.184926,"median":-7.489485,"eighty":-5.047026,"marketCap":3708178059}],"updateTime":1750113250073}}}